At day 25, we surgically removed the primary tumor and performed TCR-β repertoire sequencing to characterize the difference in T cell infiltration in the pre-metastatic lung tissue following CXCL16 antibody blocking. The gene discussed is CXCL16; the disease is neoplasm.